HLA-A*0201 & B2M & p53 (HMTEVVRRC)

HLA-A*0201 & B2M & p53 (HMTEVVRRC) Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    His Tag & Avi Tag (1)His Tag (1)

  • Conjugate

    Biotin-labeled (1)Unconjugated (1)

HLA-A*0201 & B2M & p53 (HMTEVVRRC) Background

TP53 has been recognized as a tumor suppressor. 50% of cancers carry a TP53 mutation while many others affect other pathway components. High-copy numbers of WT p53 peptide-MHC class I complexes were detected on tumor cells as compared to low copies on normal cells. The Human HLA-A*0201 p53 (HMTEVVRRC) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and HMTEVVRRC peptide of the p53.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
VT-1021VT-1021Phase 1 ClinicalVigeo Therapeutics IncSolid tumours
Details
  • Product List
  • Clinical Drug Information
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8